Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin added to anticoagulation for deep vein thrombosis
IRCT20150621022852N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin, warfarin and rivaroxaban in deep vein thrombosis (DVT) (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Prevalence of post-thrombotic phlebitis syndrome. Started Sep 2017; status: completed.
02
Drugs
rosuvastatinwarfarinrivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT20150621022852N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150621022852N4.